---
title: "Pre-market hot trades in US stocks: Aeries Tech up 8.04% in pre-market, key information boosts investor confidence, liquidity concerns intensify"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281750941.md"
description: "Aeries Tech pre-market up 8.04%; Profusa pre-market up 82.26%; Xiaoi Robot pre-market up 71.31%; BlockchAIn Digital Infrastructure pre-market up 66.38%"
datetime: "2026-04-06T10:47:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281750941.md)
  - [en](https://longbridge.com/en/news/281750941.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281750941.md)
---

# Pre-market hot trades in US stocks: Aeries Tech up 8.04% in pre-market, key information boosts investor confidence, liquidity concerns intensify

**Pre-market Hot Trades in US Stocks**

Aeries Tech is up 8.04% in pre-market trading. Based on recent key news:

1.  On April 3, Aeries Technology Inc. released important information through the EDGAR system of the U.S. Securities and Exchange Commission. The release of this information may have enhanced investor confidence in the company, driving the stock price up.
    
2.  On April 4, the company's investor base and liquidity status are closely related to its ability to maintain its listing on the exchange. The market's focus on its liquidity and market capitalization may have influenced investor trading behavior, leading to stock price fluctuations. There is an increased market focus on liquidity and market capitalization.
    

**Top Gainers in Pre-market US Stocks**

Profusa is up 82.26% in pre-market trading. Based on recent key news:

1.  On April 6, Profusa announced the signing of a letter of intent to acquire BioInsights' PanOmics molecular diagnostics platform, with a transaction amount of approximately $30 million in an all-stock deal. This move grants Profusa exclusive rights to the technology and allows for the validation of new diagnostic tests using clinical samples, significantly boosting the stock price. Source: Reuters
    
2.  On April 6, Profusa expanded its collaboration with Mayo Clinic to monitor patients before and after pancreatic surgery using the new platform. This collaboration enhances the existing Lumee real-time biochemical monitoring platform and marks significant progress in pancreatic cancer research, further boosting market confidence in the company. Source: Reuters
    
3.  On April 6, Profusa amended its financing agreement to issue $555,555.55 of 12% senior secured convertible notes to increase working capital and support business operations. This financing initiative provides the company with additional funding support to aid its business expansion. Source: SEC announcement on precision diagnostics market expansion, significant capital inflow.
    

iRobot is up 71.31% in pre-market trading, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

BlockchAIn Digital Infrastructure is up 66.38% in pre-market trading, with no significant news recently. Trading is active, and capital flow is evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation

### Related Stocks

- [AERT.US](https://longbridge.com/en/quote/AERT.US.md)

## Related News & Research

- [PRO REIT declares May 2026 cash distribution of $0.0375 per unit](https://longbridge.com/en/news/287207393.md)
- [iPhone 19 Pro Prototype in Testing Allegedly Has Quad-Curved Display](https://longbridge.com/en/news/287211514.md)
- [Should you invest $1,000 in AGNC Investment right now?](https://longbridge.com/en/news/286802595.md)
- [Fed's Goolsbee; Inflation has got to be front of mind when Warsh starts as chair](https://longbridge.com/en/news/286812315.md)
- [Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade | PPCB Stock News](https://longbridge.com/en/news/287069272.md)